Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized double-blind trial of Odiparcil versus aspirin in non-valvular atrial fibrillation
2005-001256-20Phase 2Completed
- Sponsor
- GSK
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of odiparcil in Atrial fibrillation (AFib) (2 arms), sponsored by GSK. Primary endpoint: anti-IIa activity over the course of the study. Started Sep 2005; status: completed.
02
Drugs
odiparcil
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2005-001256-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001256-20.